Dr. Patel on Ibrutinib in Real-World Setting Versus Clinical Trials
February 13th 2019Krish Patel, MD, medical oncologist, Swedish Cancer Institute, discusses a study looking at real-world benefit of BTK inhibitors versus what is seen in clinical trials for patients with mantle cell lymphoma.
Read More